ATE119776T1 - Den augeninnendruck vermindernde 11- acylprostaglandine. - Google Patents

Den augeninnendruck vermindernde 11- acylprostaglandine.

Info

Publication number
ATE119776T1
ATE119776T1 AT90308268T AT90308268T ATE119776T1 AT E119776 T1 ATE119776 T1 AT E119776T1 AT 90308268 T AT90308268 T AT 90308268T AT 90308268 T AT90308268 T AT 90308268T AT E119776 T1 ATE119776 T1 AT E119776T1
Authority
AT
Austria
Prior art keywords
acylprostaglandins
inner eye
eye pressure
compound
reduce inner
Prior art date
Application number
AT90308268T
Other languages
English (en)
Inventor
Ming Fai Chan
David Frederick Woodward
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Application granted granted Critical
Publication of ATE119776T1 publication Critical patent/ATE119776T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90308268T 1989-07-27 1990-07-27 Den augeninnendruck vermindernde 11- acylprostaglandine. ATE119776T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38683589A 1989-07-27 1989-07-27

Publications (1)

Publication Number Publication Date
ATE119776T1 true ATE119776T1 (de) 1995-04-15

Family

ID=23527257

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90308268T ATE119776T1 (de) 1989-07-27 1990-07-27 Den augeninnendruck vermindernde 11- acylprostaglandine.

Country Status (10)

Country Link
US (1) US5446041A (de)
EP (1) EP0410785B1 (de)
JP (1) JP3020260B2 (de)
AT (1) ATE119776T1 (de)
AU (1) AU635293B2 (de)
CA (1) CA2021316C (de)
DE (1) DE69017786T2 (de)
DK (1) DK0410785T3 (de)
ES (1) ES2069014T3 (de)
IE (1) IE67172B1 (de)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5312842A (en) * 1992-10-30 1994-05-17 Allergan, Inc. Cyclopentane heptenylsulfinylalkyl and heptanylsulfinylalkyl-2-aliphatic or aryl aliphatic derivatives
US5476872A (en) * 1993-10-18 1995-12-19 Allergan, Inc. 1,11-diesters of prostaglandin-F2α having a polar ester group at C-1
US5545665A (en) * 1993-12-28 1996-08-13 Allergan Cyclopentane(ene) heptenoic or heptanoic acids and derivatives thereof useful as therapeutic agents
US5698733A (en) * 1994-09-30 1997-12-16 Alcon Laboratories, Inc. Use of 9-deoxy prostaglandin derivatives to treat glaucoma
US5807892A (en) * 1994-09-30 1998-09-15 Alcon Laboratories, Inc. Use of certain prostaglandin analogues to treat glaucoma and ocular hypertension
WO1998021180A1 (en) 1995-06-07 1998-05-22 Alcon Laboratories, Inc. Conformationally rigid aryl- or heteroaryl prostaglandins for use in glaucoma therapy
US5741810A (en) 1996-02-29 1998-04-21 Allergan Cyclopentane heptan(ene)oic acid, 2- heteroarylalkenyl derivatives as therapeutic agents
CA2256404A1 (en) 1996-05-28 1997-12-04 Ming F. Chan Cyclopentan(en)oic acid, 2-alkenyl derivatives as therapeutic agents in the treatment of ocular hypertension
US6770675B2 (en) 1997-03-17 2004-08-03 Novartis Ag Compositions and methods for reducing ocular hypertension
US6248783B1 (en) 2000-09-20 2001-06-19 Allergan Sales, Inc. Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents
US6291522B1 (en) 2000-09-27 2001-09-18 Allergan Sales, Inc. Cyclopentane heptan(ENE)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
US6586462B2 (en) 2000-10-20 2003-07-01 Allergan, Inc. ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6376533B1 (en) 2000-10-20 2002-04-23 Allergan Sales, Inc. Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
US6476064B1 (en) 2001-06-13 2002-11-05 Allergan, Inc. Cyclopentane heptan(ene) acyl sulfonamide, 2-alkyl or 2-arylalkyl, or 2-heteroarylalkenyl derivatives as therapeutic agents
US7872045B2 (en) * 2001-06-14 2011-01-18 Allergan, Inc. Combination therapy for glaucoma treatment
US20050222094A1 (en) * 2001-06-14 2005-10-06 Burk Robert M Treatment of inflammatory bowel disease
US20030027853A1 (en) 2001-06-14 2003-02-06 Allergan Sales, Inc. 3, 7or3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure
BR0213911A (pt) * 2001-11-05 2004-09-28 Allergan Inc Análogos de Èmega-cicloalquil 17-heteroaril prostaglandina e2 como agonistas do receptor ep2
US6573294B1 (en) 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
US6875787B2 (en) 2003-02-11 2005-04-05 Allergan, Inc. 10,10-dialkyl prostanoic acid derivatives as agents for lowering intraocular pressure
US7855226B2 (en) * 2003-02-11 2010-12-21 Allergan, Inc. Treatment of inflammatory bowel disease
US6734201B1 (en) * 2003-06-02 2004-05-11 Allergan, Inc. 8-Azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents
US6734206B1 (en) 2003-06-02 2004-05-11 Allergan, Inc. 3-oxa-8-azaprostaglandin analogs as agents for lowering intraocular pressure
US6977260B2 (en) * 2004-01-22 2005-12-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7326716B2 (en) * 2003-06-06 2008-02-05 Allergan, Inc. Treatment of inflammatory bowel disease
WO2004108215A1 (en) * 2003-06-06 2004-12-16 Allergan, Inc. Piperidinyl prostaglandin e analogs
US6747037B1 (en) 2003-06-06 2004-06-08 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs
US7015243B2 (en) * 2003-08-28 2006-03-21 Allergan, Inc. Cyclohexyl prostaglandin analogs as EP4-receptor agonists
US7235586B2 (en) * 2003-09-09 2007-06-26 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-thiocarbamoyloxy and 2-carbamoyloxy compounds as therapeutic agents
US7169807B2 (en) * 2004-04-09 2007-01-30 Allergan, Inc. 10-Hydroxy-11-dihydroprostaglandin analogs as selective EP4 agonists
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
US7799336B2 (en) 2004-04-30 2010-09-21 Allergan, Inc. Hypotensive lipid-containing biodegradable intraocular implants and related methods
US20060182781A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Methods for treating ocular conditions with cyclic lipid contraining microparticles
WO2006014206A1 (en) * 2004-07-02 2006-02-09 Allergan, Inc. Prostaglandin analogs
US7101904B2 (en) * 2004-08-10 2006-09-05 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7183310B2 (en) * 2004-08-10 2007-02-27 Allergan, Inc. Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
US7906552B2 (en) * 2004-08-10 2011-03-15 Allergan, Inc. Cyclopentane heptan(ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
ES2399314T3 (es) * 2008-04-24 2013-03-27 Allergan, Inc. Gamma lactamas sustituidas como agentes terapeúticos
US20110136872A1 (en) * 2009-12-09 2011-06-09 Burk Robert M Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof
TR201802759T4 (tr) 2013-10-31 2018-03-21 Allergan Inc Prostamid içeren intraoküler implantlar ve kullanım yöntemleri.
BR112018005589A2 (pt) 2015-09-22 2018-10-09 Graybug Vision Inc “composto, composição farmaceuticamente aceitável, e, uso de um composto”

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4001306A (en) * 1971-12-30 1977-01-04 The Upjohn Company Prostaglandin F.sub.α 15-monoacrylates
DE2357781A1 (de) * 1972-11-28 1974-05-30 Ciba Geigy Ag Neue 15-substituierte prostansaeurederivate und verfahren zu deren herstellung
US4060540A (en) * 1975-09-18 1977-11-29 American Cyanamid Company Novel 3-triphenylmethoxy-1-alkynes, 3-triphenyl-methoxy-1-trans-alkenyl-dialkyl-alanes, and lithium 3-triphenylmethoxy-1-trans-alkenyl-dialkyl alanates
US4599353A (en) * 1982-05-03 1986-07-08 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0172963A1 (de) * 1984-08-30 1986-03-05 Ono Pharmaceutical Co., Ltd. Analoge von Prostaglandinen, Verfahren zu ihrer Herstellung und ihre Zusammenstellungen
US4883819A (en) * 1986-07-31 1989-11-28 The Trustees Of Columbia University In The City Of New York Use of A, B and C prostaglandins and derivatives thereof to treat ocular hypertension and glaucoma
US4824857A (en) * 1986-05-16 1989-04-25 Yasumasa Goh Use of prostaglandin D2 -active substances
US4822819A (en) * 1986-11-07 1989-04-18 Alcon Laboratories, Inc. Use of trimoprostil and derivatives in glaucoma therapy
ZA88963B (en) * 1987-02-27 1989-11-29 Allergan Inc Prostaglandins useful for lowering intraocular pressure
EP0286903B2 (de) * 1987-04-03 2000-03-29 The Trustees Of Columbia University In The City Of New York Anwendung eines Prostaglandins in Mischung mit einem adrenergischen Blocker zur Verminderung des Augen-Innendruckes
SE8703854D0 (sv) * 1987-10-07 1987-10-07 Pharmacia Ab Prostaglandinderivat for behandling av glaukom eller okuler hypertension

Also Published As

Publication number Publication date
EP0410785A2 (de) 1991-01-30
AU5978690A (en) 1991-01-31
DK0410785T3 (da) 1995-06-19
JPH0358931A (ja) 1991-03-14
AU635293B2 (en) 1993-03-18
EP0410785A3 (en) 1991-12-27
CA2021316A1 (en) 1991-01-28
DE69017786D1 (de) 1995-04-20
IE67172B1 (en) 1996-03-06
JP3020260B2 (ja) 2000-03-15
EP0410785B1 (de) 1995-03-15
IE902721A1 (en) 1991-02-27
US5446041A (en) 1995-08-29
ES2069014T3 (es) 1995-05-01
DE69017786T2 (de) 1995-08-03
CA2021316C (en) 2000-10-24

Similar Documents

Publication Publication Date Title
ATE119776T1 (de) Den augeninnendruck vermindernde 11- acylprostaglandine.
US5028624A (en) Intraocular pressure reducing 9,15-diacyl prostaglandins
FI902258A0 (fi) Menetelmä farmakologisesti aktiivisten 13,14-dihydro-17-fenyyli-18,19,20-trinor-PGF2 -alkyyliestereiden valmistamiseksi
LU92509I2 (fr) Travoprost et ses dérivés pharmaceutiquement acceptables (TRAVATAN)
KR960007545A (ko) 합성 흥분성 아미노산
MY102565A (en) Novel derivatives of guanine
AU8438698A (en) Prostaglandin pharmaceutical compositions
KR890006241A (ko) 설사약
DE3872701D1 (de) Prostaglandin-derivate zur behandlung von glaucoma oder augenueberdruck.
KR940702491A (ko) 옥사졸리돈 유도체
KR910019621A (ko) 상승병용을 이용한 안고혈압 치료
KR960003719A (ko) 녹내장 치료제 및 안압 강하제
DE3750464D1 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts.
EA199700287A1 (ru) Бензамиды для лечения нейродегенеративных заболеваний
ATE289817T1 (de) Arzneimittelzusammenstellung zur behandlung des erhöhten augeninnendrucks oder des glaukom
EP0399839A3 (de) Den intraokularen Druck vermindernde 15-Acylprostaglandine
KR910019622A (ko) 안과용 상승적 병용으로 안고혈압의 치료
KR920003972A (ko) 프로스타시클린 화합물을 이용한 백내장 치료
CA2402597A1 (en) Composition for use in treatment of ocular hypertension and glaucoma
KR890003372A (ko) 피리미도[2,1-b] 벤조티아졸 유도체로된 동맥경화 치료의약
KR940007010A (ko) 옥사졸리딘
KR950032113A (ko) 프로스타글란딘 에프 에스테르
BR0205932A (pt) Método e composição para tratamento de hipertensão ocular e glaucoma
KR950704322A (ko) 스피로푸라논 유도체 및 그의 신경변성 질환 치료 용도(Spirofuranone Derivatives and Their Use in the Treatment of Neurodegenerative Disorders)
JPS56139448A (en) Aminopropane derivative

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee